China News Agency, Guangzhou, Feb
23 (CAI Minjie) Zhong Nanshan, academician of the Chinese Academy of engineering, held a remote consultation with Guangdong counterpart medical team of Jingzhou Medical University in Guangzhou on Feb
23
Zhong Nanshan said that according to the current data, the epidemic situation in Jingzhou has begun to change
Jingzhou should focus on the treatment of critical patients and improve the cure rate
At the meeting, Zhong Nanshan said that the number of new cases in Hubei Province on Tuesday was 630, with the absolute number of new cases falling
Novel coronavirus pneumonia cases were confirmed in 630 cases in February 22nd, from 0 to 24 in February 22nd, including 8 cases in Jingzhou
China's novel coronavirus pneumonia has also been approved by the State Administration of drug administration, one of which is a reagent for identifying influenza, new crown pneumonia and parainfluenza, "Zhong Nan Shan said." this is a key task
In addition, two more qualified antibody kits are approved, "one of them is Wanfu biology from Guangdong Province, both of which are colloidal gold methods, which can detect LGM antibody in patients, and can detect LGM antibody on the 7th day of infection or the 3rd day of disease, which is very helpful for further diagnosis of patients." Zhong Nanshan said
Novel coronavirus products were novel coronavirus products from 3 enterprises, including 2 colloidal gold antibody detection reagents and 1 isothermal amplification chip detection methods, which expanded the detection methods and means of new coronavirus on the 22 day
The approval of the China National Drug Administration was approved by the State Administration of pharmaceuticals for emergency examination on the 3 th.
